These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 28477079)
21. Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy. Scheltema MJ; Chang JI; Böhm M; van den Bos W; Blazevski A; Gielchinsky I; Kalsbeek AMF; van Leeuwen PJ; Nguyen TV; de Reijke TM; Siriwardana AR; Thompson JE; de la Rosette JJ; Stricker PD World J Urol; 2018 Sep; 36(9):1383-1389. PubMed ID: 29594551 [TBL] [Abstract][Full Text] [Related]
22. A Multicenter, Randomized, Single-blind, 2-Arm Intervention Study Evaluating the Adverse Events and Quality of Life After Irreversible Electroporation for the Ablation of Localized Low-intermediate Risk Prostate Cancer. de la Rosette J; Dominguez-Escrig J; Zhang K; Teoh J; Barret E; Ramon-Borja JC; Muir G; Bohr J; de Reijke T; Ng CF; Leung CH; Sanchez-Salas R; Laguna P J Urol; 2023 Feb; 209(2):347-353. PubMed ID: 36441776 [TBL] [Abstract][Full Text] [Related]
23. Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback. Scheltema MJ; Postema AW; de Bruin DM; Buijs M; Engelbrecht MR; Laguna MP; Wijkstra H; de Reijke TM; de la Rosette JJMCH Diagn Interv Radiol; 2017; 23(5):365-370. PubMed ID: 28830850 [TBL] [Abstract][Full Text] [Related]
24. Irreversible electroporation: implications for prostate ablation. Onik G; Mikus P; Rubinsky B Technol Cancer Res Treat; 2007 Aug; 6(4):295-300. PubMed ID: 17668936 [TBL] [Abstract][Full Text] [Related]
25. Pilot Study to Assess Safety and Clinical Outcomes of Irreversible Electroporation for Partial Gland Ablation in Men with Prostate Cancer. Murray KS; Ehdaie B; Musser J; Mashni J; Srimathveeravalli G; Durack JC; Solomon SB; Coleman JA J Urol; 2016 Sep; 196(3):883-90. PubMed ID: 27113966 [TBL] [Abstract][Full Text] [Related]
26. Novel platinum bipolar electrode for irreversible electroporation in prostate cancer: preclinical study in the beagle prostate. Lim B; Kim HB; Jeong S; Kim SH; Kang JM; Park Y; Won DS; Kim JW; Ryu DS; Kim Y; Park JH; Kim CS Sci Rep; 2021 Aug; 11(1):17194. PubMed ID: 34433890 [TBL] [Abstract][Full Text] [Related]
28. [Irreversible electroporation: a new form of image-guided tumour ablation]. Scheffer H; Nielsen K; van Tilborg A; Vieveen JM; van den Tol MP; Meijerink MR Ned Tijdschr Geneeskd; 2014; 158():A7176. PubMed ID: 24518847 [TBL] [Abstract][Full Text] [Related]
29. First Delayed Resection Findings After Irreversible Electroporation (IRE) of Human Localised Renal Cell Carcinoma (RCC) in the IRENE Pilot Phase 2a Trial. Wendler JJ; Ricke J; Pech M; Fischbach F; Jürgens J; Siedentopf S; Roessner A; Porsch M; Baumunk D; Schostak M; Köllermann J; Liehr UB Cardiovasc Intervent Radiol; 2016 Feb; 39(2):239-50. PubMed ID: 26341653 [TBL] [Abstract][Full Text] [Related]
30. Focal irreversible electroporation as primary treatment for localized prostate cancer. van den Bos W; Scheltema MJ; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD BJU Int; 2018 May; 121(5):716-724. PubMed ID: 28796935 [TBL] [Abstract][Full Text] [Related]
31. An update on focal therapy for prostate cancer. Perera M; Krishnananthan N; Lindner U; Lawrentschuk N Nat Rev Urol; 2016 Nov; 13(11):641-653. PubMed ID: 27670618 [TBL] [Abstract][Full Text] [Related]
32. Partial gland ablation in the management of prostate cancer: a review. McClure TD; Margolis DJ; Hu JC Curr Opin Urol; 2017 Mar; 27(2):156-160. PubMed ID: 28033149 [TBL] [Abstract][Full Text] [Related]